Zobrazeno 1 - 10
of 193
pro vyhledávání: '"A. A. Kechin"'
Autor:
E. M. Polyanskaya, M. Yu. Fedyanin, U. A. Boyarskikh, A. A. Kechin, E. A. Moroz, E. A. Khrapov, I. P. Oskorobin, D. V. Shamovskaya, V. A. Aliev, Z. Z. Mammadli, A. A. Tryakin, M. L. Filipenko, S. A. Tyulendin
Publikováno v:
Успехи молекулярной онкологии, Vol 9, Iss 2, Pp 32-42 (2022)
Introduction. Studies on non-metastatic colorectal cancer have demonstrated the prognostic role of circulating tumor (ctDNA) after surgery, and the ability to identify patients with the greatest risk of progression. This makes it possible in the futu
Externí odkaz:
https://doaj.org/article/522359f026a74f06bf63b1c526809c20
Autor:
E. M. Polyanskaya, M. Yu. Fedyanin, U. A. Boyarskikh, A. A. Kechin, E. A. Moroz, A. N. Polyakov, N. E. Kudashkin, D. V. Podluzhniy, E. A. Khrapov, I. P. Oskorobin, D. V. Shamovskaya, V. A. Aliev, Z. Z. Mamedli, A. A. Tryakin, M. L. Filipenko, S. A. Tjulandin
Publikováno v:
Тазовая хирургия и онкология, Vol 12, Iss 1, Pp 27-34 (2022)
Background. Circulating tumor DnA (ctDnA) may act as a potential biomarker for predicting disease progression in patients with colorectal cancer (CRC), which are radically cured or receiving chemotherapy.Objective: to evaluate the sensitivity of the
Externí odkaz:
https://doaj.org/article/99f589873ede4c1ba404acaf9753fe7a
Publikováno v:
Сибирский онкологический журнал, Vol 20, Iss 6, Pp 120-133 (2022)
Background. The first-generation trk inhibitors, larotrectinib and entrectinib, were approved by the u.s. Food and drug administration (Fda) for the treatment of advanced solid tumors harboring NTRK gene fusions in November 2018 and in august 2019, r
Externí odkaz:
https://doaj.org/article/95352437ab884d28b9d3fa3186cf87a3
Autor:
Ulyana A. Boyarskikh, L. F. Gulyaeva, A. M. Avdalyan, A. A. Kechin, E. A. Khrapov, D. G. Lazareva, N. E. Kushlinskii, A. Melkonyan, A. Arakelyan, Maxim Leonidovich Filipenko
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Objective: Mutations in TP53 lead to loss of function (LOF) or gain of function (GOF) of the corresponding protein p53 and produce a different effect on the tumor. Our goal was to determine the spectrum of somatic TP53 variants in BRCA1/2 associated
Externí odkaz:
https://doaj.org/article/6212bc92777a484e94d370ba926d020e
Autor:
M. Yu. Fedyanin, Kh. Kh.-M. Elsnukaeva, V. A. Aliev, T. S. Ayrapetyan, A. V. Polyakov, E. V. Moroz, V. A. Uymanov, U. A. Boyarskikh, A. A. Kechin, M. L. Filipenko, S. А. Tjulandin
Publikováno v:
Тазовая хирургия и онкология, Vol 8, Iss 3, Pp 11-16 (2018)
Colon cancer is the 3rd most common malignant neoplasm and the 4th leading cause of mortality from them. The majority of patients are diagnosed at stages II–IV, which indicates the need for markers that can predict disease progression, especially a
Externí odkaz:
https://doaj.org/article/ab372d1968ee42b2bc22fe2a90273fb0
Autor:
A. A. Kechin, D. S. Boldyreva, M. A. Makarova, L. A. Kaftyreva, S. G. Scherbak, S. V. Apalko, M. L. Filipenko, A. M. Sarana, M. A. Churina
Publikováno v:
Инфекция и иммунитет, Vol 8, Iss 4, Pp 513-514 (2018)
Externí odkaz:
https://doaj.org/article/15516033842b4ccaadd365b29000c648
Autor:
Lipunov, V., Kornilov, V., Zhirkov, K., Tyurina, N., Gorbovskoy, E., Vlasenko, D., Simakov, S., Topolev, V., Francile, C., Podesta, R., Podesta, F., Svinkin, D., Budnev, N., Gress, O., Balanutsa, P., Kuznetsov, A., Chasovnikov, A., Serra-Ricart, M., Gabovich, A., Minkina, E., Antipov, G., Svertilov, S., Tlatov, A., Senik, V., Tselik, Yu., Kechin, Ya., Yurkov, V.
Publikováno v:
MNRAS 514, 4, 4980-4987 (2022)
We report on MASTER optical observations of an afterglow-like optical and X-ray transient AT2021lfa/ZTF21aayokph. We detected the initial steady brightening of the transient at 7{\sigma} confidence level. This allowed us to use smooth optical self-si
Externí odkaz:
http://arxiv.org/abs/2302.05924
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Boyarskikh, Ulyana1 (AUTHOR) boyarskih.u@gmail.com, Kechin, Andrey1 (AUTHOR) max@niboch.nsc.ru, Khrapov, Evgeniy1 (AUTHOR), Fedyanin, Mikhail2 (AUTHOR), Raskin, Grigory3 (AUTHOR) rasking@list.ru, Mukhina, Marina3 (AUTHOR) mukhina@ldc.ru, Kravtsova, Elena3 (AUTHOR), Tsukanov, Aleksey4 (AUTHOR), Achkasov, Sergey4 (AUTHOR), Filipenko, Maksim1 (AUTHOR)
Publikováno v:
Cancers. Oct2023, Vol. 15 Issue 20, p5065. 13p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.